Erythroblastosis, Fetal D004899

Related MeSH Hierarchy (5)

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Erythroblastosis, Fetal

Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Fetal Diseases » Erythroblastosis, Fetal

Diseases [C] » Immune System Diseases [C20] » Erythroblastosis, Fetal

Description

A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.   MeSH

Subtype Terms (2)

Hydrops Fetalis
1 experimental drug

Kernicterus
1 experimental drug


Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (1)

Phase 2 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 3 Indications (2)

Organization Involved with Phase 2 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.